Podcasts about palo alto

Listen Now to 136 Future Now Show I am writing this summary of this week’s show from the island of Maui, in Hawaii.  It’s been a wild week, starting with a trip to the rugged and wild Farallon Islands, 25 miles of the coast of San Francisco, home to copious wildlife, fish, marine mammals, and the great white sharks.  Getting there was harrowing, with very rought seas, but the sun broke through as we arrived revealing the majestic Farallons through the dissapating mist.  All of us had something to share about our experienes there in today’s show! And naturally we keep you up to date on the latest with 3I/ATLAS, though by the time you read this the perihelion has happened, with wthatever it has to reveal about any sentience behind it’s actions…  And in the second hour you will meet three visiting Nordics to Silicon Valley, involved with what’s known as “Clean Tech,” and the unfolding use of AI in developing the energy sector of our human civilization. We met at the start of Nordic Impact Week, at the Nordic Innovation House in Palo Alto, CA, and carried on for today’s show. The Nordics have an extemely sophisticated energy infrastruction for power sharing in Scandinavia and are in Silicon Valley to scale their advanced use of technology to the larger world, starting with us! Enjoy.. Our intrepid crew returning from the Farallon Islands

Shopping is transforming faster than shelves can restock. From smart carts to AI fashion advisors, the way we browse, buy, and return is being re-engineered by data. R-J Hottovy, Head of Analytical Research at Palo Alto–based foot traffic analysis firm Placer.AI, joins Rob Hart on the WBBM Noon Business Hour to discuss.

By the time you implement “best practices,” they've become boring practices, and B2B sure doesn't mean boring to business. In this episode, Drew talks with Udi Ledergor (Gong), author of Courageous Marketing, the book that challenges B2B marketers to stop playing it safe. Together, they explore what it means to lead with creativity, confidence, and courage. Udi also shares how Gong earned attention by building an audience that wanted to engage, not just be targeted. With every executive, from the CEO to the CFO, invested in the story, marketing became a company-wide advantage instead of a department.  Three B2B Marketing Traps Udi Warns Against:  Following industry best practices instead of breaking them  Letting marketing own brand alone  Hiring for experience over potential Plus:  The punch-above-your-weight framework that makes a startup look enterprise-ready  Why brand must be led by the CEO and modeled across the exec team  How to hire for curiosity, learning speed, and potential  How to sell the 95–5 content mindset to your CEO and CFO If you're done blending in, this conversation will remind you why courage still wins in B2B. Udi will be speaking at the CMO Super Huddle in Palo Alto on November 7th, 2025. All attendees will receive a complimentary copy of his book, Courageous Marketing, and can get it signed in the morning!  For full show notes and transcripts, visit https://renegademarketing.com/podcasts/ To learn more about CMO Huddles, visit https://cmohuddles.com/

A candid conversation with Navin Budhiraja, CTO and Head of Products at Vianai Systems, Inc. on The Ravit Show in Palo Alto. From Bhilai to Palo Alto. Navin topped the IIT entrance exam, studied at Cornell, and led at IBM, AWS, and SAP. We sat down to talk about building AI that enterprises can actually use.What we covered:- Vianai's mission and the hila platform: why it exists and the problem it solves- How hila turns enterprise data into something teams can interact with in plain language- Responsible AI in practice: tackling hallucinations and earning trust- Why a platform like hila is needed even with powerful foundation models- Conversational Finance: what makes it useful for finance teams- Real integrations: ERP, CRM, HR systems, and how this works end to end- Security for the real world: air-gapped deployments, privacy, and certifications- The road ahead: how AI, IoT, and cloud are converging in the next 2 to 3 years- Advice for the next generation of builders from Bhilai, the IITs, and beyondWhy this matters:Enterprises want outcomes, not hype. Navin's lens on trust, flexibility, and scale shows how AI moves from pilot to production.Thank you, Navin, for the clear thinking and straight answers. Full interview on The Ravit Show YouTube channel is live.#data #ai #vianai #theravitshow

 Fabio Vighi visited the United States giving a series of talks at Stanford University in Palo Alto.  A number of us from “What's Left?” Had the opportunity to both see one of his presentations and also spend a few days together checking out San Francisco and talking politics.  We take a moment to talk about how fun and meaningful it was for us. Check us out!Interview with Fabio Vighihttps://youtu.be/iTJsGBcwuQEEmergency Capitalismhttps://sublationmedia.com/product/emergency-capitalism/Fabio Vighi on The Philosophical Salonhttps://www.thephilosophicalsalon.com/author/fabiovighi/page/2/ https://youtu.be/nItmqkrpWHU To see all our episodes go to:What's Left? Website: https://whatsleftpodcast.com/iTunes: Spotify: Bitchute: YouTube:  LBRY: Telegram :Odysee:  Googleplaymusic: Rumble 

In this bonus episode of The Big Ben Show, host Ben Domenech sits down with Brent Scher, editor-in-chief at The Daily Wire for a candid discussion on the future of journalism and political media. They explore how the news landscape is shifting, what independent media means for public trust, and how new voices are challenging legacy outlets. From newsroom culture and political coverage to the influence of social platforms, Ben and Brent unpack what's changing and what journalists, creators, and audiences should expect next. Recorded in Palo Alto, this wide-ranging conversation offers sharp insights into media, politics, and the evolving role of storytelling in democracy. What do you think is the biggest change in journalism today?  

In this episode, Dr. Dave Chatterjee speaks with Anupam Upadhyay, Senior Vice President, Product Management, Palo Alto Networks, a seasoned product and cybersecurity leader, to unpack the “new browser wars” and why enterprise browsers are fast becoming a core battleground in the fight for digital trust. Drawing on over two decades of experience spanning Cisco, startups, and Palo Alto, Upadhyay traces the evolution of the humble browser from a passive content viewer into the primary interface for cloud applications, collaboration tools, and sensitive business data.The conversation examines the browser's expanding role as both a productivity hub and a primary attack vector—accounting for over 90 percent of initial intrusions via phishing, malicious extensions, or session hijacking. Through the lens of the Commitment-Preparedness-Discipline (CPD) Framework, Dr. Chatterjee and Anupam Upadhyay emphasize that securing the enterprise browser is not merely a technical exercise but a governance imperative: leadership commitment to zero-trust principles, preparedness through hardened configurations and employee training, and disciplined enforcement of consistent controls across devices and partners.Time Stamps• 00:49 — Dave's introduction and guest overview.• 03:00 — Anupam Upadhyay's career journey and reinvention at Palo Alto Networks.• 05:00 — Historical context: how browsers stayed outside the security spotlight.• 08:40 — Cloud and SaaS migration shifting business to the browser.• 11:20 — Emerging browser threats and data sanctity concerns.• 14:30 — Malicious extensions and the limits of traditional EDR.• 16:07 — Browser security as part of Zero Trust architecture.• 18:30 — Balancing security and user experience.• 22:10 — Operating in hostile environments and credential revocation.• 25:00 — Dr. Chatterjee introduces the CPD framework for governance.• 28:45 — Implementation and user adoption challenges.• 30:00 — Continuous testing and discipline in browser security.• 33:05 — Closing takeaways on Zero Trust mindset and defense-in-depth.Podcast summary with discussion highlights - https://www.dchatte.com/episode-93-the-new-browser-wars-why-the-enterprise-browser-has-become-cybersecuritys-next-battleground/Connect with Host Dr. Dave Chatterjee LinkedIn: https://www.linkedin.com/in/dchatte/ Website: https://dchatte.com/Books PublishedThe DeepFake ConspiracyCybersecurity Readiness: A Holistic and High-Performance ApproachArticles PublishedRamasastry, C. and Chatterjee, D. (2025). Trusona: Recruiting For The Hacker Mindset, Ivey Publishing, Oct 3, 2025.Chatterjee, D. and Leslie, A. (2024). “Ignorance is not bliss: A...

BONUS: The Evolution of Agile - From Project Management to Adaptive Intelligence, With Mario Aiello In this BONUS episode, we explore the remarkable journey of Mario Aiello, a veteran agility thinker who has witnessed and shaped the evolution of Agile from its earliest days. Now freshly retired, Mario shares decades of hard-won insights about what works, what doesn't, and where Agile is headed next. This conversation challenges conventional thinking about methodologies, certifications, and what it truly means to be an Agile coach in complex environments. The Early Days: Agilizing Before Agile Had a Name "I came from project management and project management was, for me, was not working. I used to be a wishful liar, basically, because I used to manipulate reports in such a way that would please the listener. I knew it was bullshit." Mario's journey into Agile began around 2001 at Sun Microsystems, where he was already experimenting with iterative approaches while the rest of the world was still firmly planted in traditional project management. Working in Palo Alto, he encountered early adopters discussing Extreme Programming and had an "aha moment" - realizing that concepts like short iterations, feedback loops, and learning could rescue him from the unsustainable madness of traditional project management. He began incorporating these ideas into his work with PRINCE2, calling stages "iterations" and making them as short as possible. His simple agile approach focused on: work on the most important thing first, finish it, then move to the next one, cooperate with each other, and continuously improve. The Trajectory of Agile: From Values to Mechanisms "When the craze of methodologies came about, I started questioning the commercialization and monetization of methodologies. That's where things started to get a little bit complicated because the general focus drifted from values and principles to mechanisms and metrics." Mario describes witnessing three distinct phases in Agile's evolution. The early days were authentic - software developers speaking from the heart about genuine needs for new ways of working. The Agile Manifesto put important truths in front of everyone. However, as methodologies became commercialized, the focus shifted dangerously away from the core values and principles toward prescriptive mechanisms, metrics, and ceremonies. Mario emphasizes that when you focus on values and principles, you discover the purpose behind changing your ways of working. When you focus only on mechanics, you end up just doing things without real purpose - and that's when Agile became a noun, with people trying to "be agile" instead of achieving agility. He's clear that he's not against methodologies like Scrum, XP, SAFe, or LeSS - but rather against their mindless application without understanding the essence behind them. Making Sense Before Methodology: The Four-Fit Framework "Agile for me has to be fit for purpose, fit for context, fit for practice, and I even include a fourth dimension - fit for improvement." Rather than jumping straight to methodology selection, Mario advocates for a sense-making approach. First, understand your purpose - why do you want Agile? Then examine your context - where do you live, how does your company work? Only after making sense of the gap between your current state and where the values and principles suggest you should be, should you choose a methodology. This might mean Scrum for complex environments, or perhaps a flow-based approach for more predictable work, or creating your own hybrid. The key insight is that anyone who understands Agile's principles and values is free to create their own approach - it's fundamentally about plan, do, inspect, and adapt. Learning Through Failure: Context is Paramount "I failed more often than I won. That teaches you - being brave enough to say I failed, I learned, I move on because I'm going to use it better next time." Mario shares pivotal learning moments from his career, including an early attempt to "agilize PRINCE2" in a command-and-control startup environment. While not an ultimate success, this battle taught him that context is paramount and cannot be ignored. You must start by understanding how things are done today - identifying what's good (keep doing it), what's bad (try to improve it), and what's ugly (eradicate it to the extent possible). This lesson shaped his next engagement at a 300-person organization, where he spent nearly five months preparing the organizational context before even introducing Scrum. He started with "simple agile" practices, then took a systems approach to the entire delivery system. A Systems Approach: From Idea to Cash "From the moment sales and marketing people get brilliant ideas they want built, until the team delivers them into production and supports them - all that is a system. You cannot have different parts finger-pointing." Mario challenges the common narrow view of software development systems. Rather than focusing only on prioritization, development, and testing, he advocates for considering everything that influences delivery - from conception through to cash. His approach involved reorganizing an entire office floor, moving away from functional silos (sales here, marketing there, development over there) to value stream-based organization around products. Everyone involved in making work happen, including security, sales, product design, and client understanding, is part of the system. In one transformation, he shifted security from being gatekeepers at the end of the line to strategic partners from day one, embedding security throughout the entire value stream. This comprehensive systems thinking happened before formal Scrum training began. Beyond the Job Description: What Can an Agile Coach Really Do? "I said to some people, I'm not a coach. I'm just somebody that happens to have experience. How can I give something that can help and maybe influence the system?" Mario admits he doesn't qualify as a coach by traditional standards - he has no formal coaching qualifications. His coaching approach comes from decades of Rugby experience and focuses on establishing relationships with teams, understanding where they're going, and helping them make sense of their path forward. He emphasizes adaptive intelligence - the probe, sense, respond cycle. Rather than trying to change everything at once and capsizing the boat, he advocates for challenging one behavior at a time, starting with the most important, encouraging adaptation, and probing quickly to check for impact of specific changes. His role became inviting people to think outside the box, beyond the rigidity of their training and certifications, helping individuals and teams who could then influence the broader system even when organizational change seemed impossible. The Future: Adaptive Intelligence and Making Room for Agile "I'm using a lot of adaptive intelligence these days - probe, sense, respond, learn and adapt. That sequence will take people places." Looking ahead, Mario believes the valuable core of Agile - its values and principles - will remain, but the way we apply them must evolve. He advocates for adaptive intelligence approaches that emphasize sense-making and continuous learning rather than rigid adherence to frameworks. As he enters retirement, Mario is determined to make room for Agile in his new life, seeking ways to give back to the community through his blog, his new Substack "Adaptive Ways," and by inviting others to think differently. He's exploring a "pay as you wish" approach to sharing his experience, recognizing that while he may not be a traditional coach or social media expert, his decades of real-world experience - with its failures and successes - holds value for those still navigating the complexity of organizational change. About Mario Aiello Retired from full-time work, Mario is an agility thinker shaped by real-world complexity, not dogma. With decades in VUCA environments, he blends strategic clarity, emotional intelligence, and creative resilience. He designs context-driven agility, guiding teams and leaders beyond frameworks toward genuine value, adaptive systems, and meaningful transformation. You can link with Mario Aiello on LinkedIn, visit his website at Agile Ways.

3️⃣ straight losses. A fanbase in existential crisis. And now the Noles are flying west — not for fun, not for In-N-Out, but for salvation.Can Florida State stop the bleeding in Palo Alto? Or are we watching the slow-motion collapse of a once-promising 2025 campaign?Vince and Ryan break it all down: • What's actually broken with FSU • Why the Stanford game might be Norvell's gut check moment • The “if we win, does it even matter?” conversation • A travel map more chaotic than our offenseOh, and #NoleNation isn't the only group on #CoachWatch...

If you have a tip, please call 1-800-CALL-FBI (1-800-225-5324) or call the anonymous national hotline at 1-800-222-TIPS (8477), or visit the official Crime Stoppers USA website to submit a tip online. This service is available 24/7 and allows you to provide information about a crime anonymously, which may make you eligible for a reward if your tip leads to an arrest.Somewhere in the Pines is sponsored by Better Help and Hello FreshOn June 23nd or June 30th, 2006 , 52 year old experienced outdoorsman Mike Mason was last seen at the Dungeness Forks Campground. A secluded campground just inside the northeastern border of the Olympic National Forest and a 12 mile drive from Sequim, Wa. via Palo Alto rd. This Episode we speak with Mike's  sister, Kay, to understand what could have led Mike to be in a vulnerable position as the week unfolded. As we uncover a new piece of evidence that could help lead to answers in Mike's case.Special Guests:KayResources:The FBI filesTrue Crime Bullsh**Researchers:Peggy S.Kim K.Haydn D.Heather H.Drew R.Music: Deadwood Revival - Come see me sometimeInstgram @DeadwoodrevivalduoAs always, a very special Thank you to our Patreon producers:Heather Horton WhedonNicole GuzmanLynnlie TuschoffColleen SullivanAttar MannStephanie MaksimowKatelyn JamesKathy NationBrian HannaTristaAllyPinkDale AkstinCorey Deatly Virginia WilliamsAmeh JarisJim FreemanAnd StephanieSomewhere in the pines created by Joshua Ash and Dakota Williams

In this episode of Take-Away with Sam Oches, Sam talks with Lars Smith, chef and owner of State of Mind Pub in Palo Alto, Calif., and Abby Hughes, head of growth strategy for Belle Communication. They've been tracking the rise of chef content on Instagram and TikTok, and joined the podcast to share their tips both for chefs and foodservice businesses on how to leverage chefs for exposure in the age of social media, and why authenticity is key to any partnership between a brand and a chef. In this conversation, you'll find out why:The industry continues to turn to social media for menu inspirationThere's nobody better suited to inspire menu innovation on social media than chefs If you have a particular SKU you're trying to push, a chef can helpThe best chef partnerships are those that are authentic Most restaurateurs don't have time for the formal foodservice channels Have feedback or ideas for Take-Away? Email Sam at sam.oches@informa.com.

In this week's special Nordic Visionaries episode on the Innovation Storytellers Show, I enjoyed a conversation that started at TechBBQ in Copenhagen and quickly stretched from refugee camps in Kenya to data centers in Norway and boardrooms in Silicon Valley. I sat down with Soulaima Gourani, a Moroccan-Danish entrepreneur now based in Palo Alto, for this special episode supported by the EU Nordic Council of Ministers and the governments of Norway, Denmark, Sweden, and Finland.  Soulaima shares how she went from growing up in remote Danish towns and troubled neighborhoods to becoming a VC-backed founder, keynote speaker, and author. She describes a life built on agency and resilience, from leaving home young and navigating early setbacks to discovering flow in a full calendar. Her line that pressure is a privilege sets the tone for a candid look at ambition, stamina, and the choices that shape a founder's path. We unpack her two current ventures, Happioh and Ailo. At Happioh, she is building an AI agent gym and a meeting spam filter that lives in the pre-meeting space, where agendas get fixed, invites improve, and agents are monitored and taken off air the moment they drift. That same scaffolding is supporting a healthcare use case in low-resource settings, where AI can nudge junior clinicians to ask the right questions and auto-complete forms so scarce doctors can see more patients with greater focus.  Storytelling runs through the entire discussion. Soulaima breaks down how she learned the language of venture, sharpened her narrative, and raised capital from scores of investors over Zoom. She talks openly about the realities of governance, the discipline of staying forever in beta, and the difference between being busy and being productive.  We also explore what the Nordics contribute to global innovation culture, from emotional intelligence and community orientation to the need to think bigger from day one. In the hot seat, she picks the internet as the greatest innovation, dreams about joining a space program, and makes a heartfelt case for curing cancer, noting why AI gives her real confidence that progress will arrive faster than many expect.  

Reid Hoffman's relationship with Jeffrey Epstein is tenuous, controversial, and wrapped in layers of public explanation and regret. Hoffman has admitted that he invited Epstein to a 2015 dinner in Palo Alto (with luminaries like Elon Musk and Mark Zuckerberg) as part of fundraising efforts for the MIT Media Lab—on the basis that MIT leadership had “vetted” Epstein. He later issued a public apology, saying that while he believed the invitation was appropriate at the time, it was a serious error in judgment to associate with Epstein post-conviction.But deeper reporting has further complicated Hoffman's narrative. Documents indicate that Hoffman visited Epstein's private island, Little St. James, in 2014 (after Epstein's 2008 conviction), apparently connected with MIT-related fundraising. Other records show plans for Hoffman to stay in Epstein's New York townhouse and attend social engagements with him and other tech elites. Hoffman's defenders say his ties were limited to philanthropy and fundraising, but critics argue that even those interactions — especially occurring after Epstein's well-known legal disgrace — raise troubling questions about judgment, complicity, and the degree to which Epstein was able to rehab his social capital among elite tech circles.to contact me:bobbycapucci@protonmail.com

Wearing the CMO+ hat rewires the role. You pick up a second lane, your calendar tightens, and perceptions shift from “just the marketer,” a label no one should wear, to business leader.   The path is demanding, but when the plus lines up with company priorities and earns trust across the business, the impact is unmistakable.   In this episode, Drew sits down with Sandy Ono, EVP and CMO at OpenText, who leads global marketing across ten business units while also owning partnerships and alliances. She treats both as one go-to-market, aligning partners and the field around a single story, running the forecast together, and keeping a steady rhythm so co-selling and co-marketing stay aimed at the same targets.  Three Actions Behind Sandy's CMO+ Success: Mindset: Claim growth as the job and step closer to revenue through partnerships  Skillset: Learn forecasting, deal construction, and the weekly rigor of partner sales  Toolset: Build the operating rhythm that connects co-selling, co-marketing, and accountability at scale  Plus:  How to choose a plus that aligns with company growth priorities  How to juggle both roles with capacity planning and clear priorities  How to protect brand integrity while telling a shared story with partners  How to measure progress with sourced pipeline, influenced revenue, retention, and feedback loops into product Weighing a plus or already living one? You'll find proven moves here.   If you're a B2B CMO, you can meet Sandy and another 100 incredible marketing leaders at the CMO Super Huddle in Palo Alto, California on November 6th and 7th. She'll be speaking on a panel about how CMOs are leading the charge with GenAI.  For full show notes and transcripts, visit https://renegademarketing.com/podcasts/ To learn more about CMO Huddles, visit https://cmohuddles.com/

This week brings some new insights into the origins and length of the Cl0p extortion attacks tied to the Oracle E-Business Suite vulnerability, big surges in scanning for Cisco ASA, Palo Alto, and Fortinet devices, and a huge upgrade to Apple bug bounty payouts.  Plus: Does Dennis have a dog yet?https://security.apple.com/blog/apple-security-bounty-evolved/https://decipher.sc/2025/10/08/data-connects-scanning-surges-for-cisco-fortinet-pan-devices/https://decipher.sc/2025/10/09/oracle-clop-data-theft-campaign-started-months-ago/

Reid Hoffman's relationship with Jeffrey Epstein is tenuous, controversial, and wrapped in layers of public explanation and regret. Hoffman has admitted that he invited Epstein to a 2015 dinner in Palo Alto (with luminaries like Elon Musk and Mark Zuckerberg) as part of fundraising efforts for the MIT Media Lab—on the basis that MIT leadership had “vetted” Epstein. He later issued a public apology, saying that while he believed the invitation was appropriate at the time, it was a serious error in judgment to associate with Epstein post-conviction.But deeper reporting has further complicated Hoffman's narrative. Documents indicate that Hoffman visited Epstein's private island, Little St. James, in 2014 (after Epstein's 2008 conviction), apparently connected with MIT-related fundraising. Other records show plans for Hoffman to stay in Epstein's New York townhouse and attend social engagements with him and other tech elites. Hoffman's defenders say his ties were limited to philanthropy and fundraising, but critics argue that even those interactions — especially occurring after Epstein's well-known legal disgrace — raise troubling questions about judgment, complicity, and the degree to which Epstein was able to rehab his social capital among elite tech circles.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-moscow-murders-and-more--5852883/support.

Reid Hoffman's relationship with Jeffrey Epstein is tenuous, controversial, and wrapped in layers of public explanation and regret. Hoffman has admitted that he invited Epstein to a 2015 dinner in Palo Alto (with luminaries like Elon Musk and Mark Zuckerberg) as part of fundraising efforts for the MIT Media Lab—on the basis that MIT leadership had “vetted” Epstein. He later issued a public apology, saying that while he believed the invitation was appropriate at the time, it was a serious error in judgment to associate with Epstein post-conviction.But deeper reporting has further complicated Hoffman's narrative. Documents indicate that Hoffman visited Epstein's private island, Little St. James, in 2014 (after Epstein's 2008 conviction), apparently connected with MIT-related fundraising. Other records show plans for Hoffman to stay in Epstein's New York townhouse and attend social engagements with him and other tech elites. Hoffman's defenders say his ties were limited to philanthropy and fundraising, but critics argue that even those interactions — especially occurring after Epstein's well-known legal disgrace — raise troubling questions about judgment, complicity, and the degree to which Epstein was able to rehab his social capital among elite tech circles.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

What's it like to live in San Carlos, California — “The City of Good Living”?In this series, we explore the most desirable communities across the Bay Area — giving you an insider's look at where locals live, work, and play. Whether you're relocating, investing, or just exploring your options, this is the BEST vlog series for understanding the lifestyle, real estate, and amenities in top Bay Area neighborhoods.This week, we're heading to San Carlos, one of the most charming and well-connected cities on the Peninsula. With top-rated schools, a vibrant downtown, and stunning hillside views, San Carlos blends small-town comfort with Silicon Valley convenience — earning its official title as The City of Good Living.

This week on Swimming with Allocators, Michael Downing, serial entrepreneur and venture investor, shares his journey from founding startups to building MDSV Capital, while diving into the essential role of emerging manager funds in today's venture landscape. The discussion covers the evolution of venture capital, key strategies for both LPs and GPs, the importance of innovative sourcing and community-building, and how the Promontory platform fosters stronger connections and investment outcomes. Listeners will take away insights on industry shifts, the value of supporting innovative early-stage funds, practical guidance for thriving amid changing venture dynamics, and so much more.Highlights from this week's conversation include:Michael's Entrepreneurial Journey & Early Startups (1:20)Transition from Founder to Investor and Early Micro VC Experience (5:23)Power Law, Missed Opportunities, and Emerging Manager Alpha (9:57)Capital Extension Structure & Alignment with Managers (14:13)Filtering and Assessing Emerging Managers in a Crowded Market (16:52)Common LP Misunderstandings and Venture Capital Dynamics (19:22)Insider Segment: Trends in LP Activity and Fund Composition (22:20)Direct Investment vs. Fund Commitment by LPs (25:14)Trends Managers Are Missing & Seed Funding Explosion (25:54)Sourcing Methodology and the Platform Approach Advantage (28:48)Criteria for Managers to Engage with Michael Downing (29:05)Deep Tech/Defense Tech Priority & Generalist Outperformance (33:41)Best Practices for Building Relationships with LPs via Promontory (35:33)Future Vision: Programmatic LP Allocation and Software Approach (38:28)Final Thoughts and Takeaways (40:30)MDSV Capital is a Palo Alto-based investment firm led by Silicon Valley veterans with over two decades of entrepreneurial and venture experience. The firm has built a premier ecosystem of top-tier emerging manager funds (EMFs) and LPs through its invitation-only community, The Promontory, and its Emerging Horizons event series. MDSV's Emerging Manager Alpha at Scale strategy targets the top 1% of emerging managers while investing directly in early-growth outliers from their portfolios. Learn more at www.mdsvcapital.com.Sidley Austin LLP is a premier global law firm with a dedicated Venture Funds practice, advising top venture capital firms, institutional investors, and private equity sponsors on fund formation, investment structuring, and regulatory compliance. With deep expertise across private markets, Sidley provides strategic legal counsel to help funds scale effectively. Learn more at sidley.com.Swimming with Allocators is a podcast that dives into the intriguing world of Venture Capital from an LP (Limited Partner) perspective. Hosts Alexa Binns and Earnest Sweat are seasoned professionals who have donned various hats in the VC ecosystem. Each episode, we explore where the future opportunities lie in the VC landscape with insights from top LPs on their investment strategies and industry experts shedding light on emerging trends and technologies. The information provided on this podcast does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this podcast are for general informational purposes only. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Bad Crypto, Blood Thirsty Zombie CPUs, Y2K38, Park Mobile, Palo Alto, Redis, Red Hat, Deloitte, Aaran Leyland, and more on the Security Weekly News. Visit https://www.securityweekly.com/swn for all the latest episodes! Show Notes: https://securityweekly.com/swn-518

Bad Crypto, Blood Thirsty Zombie CPUs, Y2K38, Park Mobile, Palo Alto, Redis, Red Hat, Deloitte, Aaran Leyland, and more on the Security Weekly News. Show Notes: https://securityweekly.com/swn-518

Bad Crypto, Blood Thirsty Zombie CPUs, Y2K38, Park Mobile, Palo Alto, Redis, Red Hat, Deloitte, Aaran Leyland, and more on the Security Weekly News. Visit https://www.securityweekly.com/swn for all the latest episodes! Show Notes: https://securityweekly.com/swn-518

Bad Crypto, Blood Thirsty Zombie CPUs, Y2K38, Park Mobile, Palo Alto, Redis, Red Hat, Deloitte, Aaran Leyland, and more on the Security Weekly News. Show Notes: https://securityweekly.com/swn-518

Today, I am thrilled to connect with Dr. Elizabeth Yurth. Dr. Yurth is double board-certified, as a physician in physical medicine and rehabilitation in addition to anti-aging and regenerative medicine. With over 30 years of clinical experience, Dr. Yurth continues to lead the way in orthopedics, cellular and regenerative medicine, and the future of aging. In our conversation, we explore immunosenescence and its implications for longevity. We discuss the off-label utilization of medications, including low-dose naltrexone, rapamycin, and GLP-1s, and examine other types of peptides, growth hormone secretagogues, and thymic peptides. We speak about hormones and anabolics, highlighting the benefits of anabolics for the bone health of those with osteopenia and osteoporosis. Dr. Yurth also shares her favorite supplements and outlines the key elements for optimal brain health. This episode is the first of a series of conversations with Dr. Yurth. She will join us again to dive into cardiovascular disease and explore powerful ways to support healthy aging at the cellular level. IN THIS EPISODE, YOU WILL LEARN: Why the thymus gland shrinks with age and what that means for immunity How thymic peptides support immune health, healing, and recovery The role thymosin alpha-1 plays in modulating the immune system Why thymosin beta-4 must be cycled for safe healing support How IGF (Insulin-like Growth Factor) decline impacts muscles, joints, and the brain with aging How growth hormone secretagogues can safely raise IGF How BPC-157 (a gastric peptide) aids gut repair, musculoskeletal healing, and brain protection Why mitochondrial peptides matter for energy, recovery, and repair How anabolics support bone strength and recovery How creatine and choline support the brain and muscles Bio: Elizabeth Yurth, MD, ABPMR, ABAARM, FAARM, FAARFM, FSSRP, is Co-Founder and Chief Medical Officer of Boulder Longevity Institute, where she has been providing Tomorrow's Medicine Today to her clients since 2006.  Dr. Yurth obtained her Medical Degree from the University of Southern California Keck School of Medicine, completed her residency at the University of California – Irvine, and her Fellowship in Sports and Spine Medicine from Stanford-affiliated Sports Orthopedics and Rehabilitation (SOAR) in Palo Alto, CA., along with her 30 years as a practicing orthopedist specializing in sports and spine medicine.  Dr. Yurth has made it her mission to learn and share the latest scientific research on how to truly heal the body at the cellular level. She is Fellowship trained in Anti-Aging, Regenerative, and Cellular Medicine. She has completed +500 hours of CME training focused on Longevity, Nutrition, Epigenetics, Bioidentical Hormone Replacement Therapy, Regenerative Peptide Treatments, and Regenerative Orthopedic Procedures.  Dr. Yurth continues to serve as a thought leader in Cellular Medicine, speaking at longevity events across the world and teaching others through her position as a founding faculty member for Seeds Scientific Research and Performance Institute (SSRP), which leads the way in connecting the latest research to clinical practice. Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Elizabeth Yurth On her website Dr. Yurth on Facebook The Boulder Longevity Institute on Facebook Dr. Yurth on Instagram The Boulder Longevity Institute on Instagram

“How are we going to show up in LLMs?”  That's the new CEO question keeping B2B CMOs on alert. As AI-powered search reshapes how buyers find answers, B2B brands need a new organic strategy—Answer Engine Optimization (AEO). In this episode, Drew Neisser brings together two AEO trailblazers: Guy Yalif (Webflow) and Omer Gottlieb (Salespeak). Together, they tackle what it really takes to earn your place in AI answers. Forget keyword stuffing—this is about understanding how LLMs ingest, rank, and cite information, and how B2B marketers can respond now. You'll learn how to earn placement in AI-generated answers by mastering the four pillars of AEO: Content: Answer real buyer questions clearly and concisely.  Technical: Make your site machine-readable.  Authority: Earn credibility where buyers AND models are looking.  Measurement: Track share of voice across critical questions, then iterate. Also in this episode:  What LLMs want—but often can't find—on B2B websites  How to build a question-driven content strategy using sales calls, support tickets, and win-loss data.  Why share of voice (across buyer questions) is the new metric for AI visibility.  How to serve two audiences at once: humans and machines 

Three Buddy Problem - Episode 66: We discuss drone sightings that shut down airports across Europe and what they reveal about hybrid warfare and the changing nature of conflict; Oracle ransomware/extortion campaign tied to unpatched E-Business Suite vulnerabilities and the company's muted response. Plus, the TikTok–Oracle deal and the strange role Oracle now plays in U.S. national security; OpenAI's Sora 2 launch and its implications for social media and human expression; Palo Alto's “Phantom Taurus” APT report, a follow-up on Cisco's ArcaneDoor disclosures, and the impact of the U.S. government shutdown on CISA. Cast: Juan Andres Guerrero-Saade (https://twitter.com/juanandres_gs), Ryan Naraine (https://twitter.com/ryanaraine) and Costin Raiu (https://twitter.com/craiu).

Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

McDonald's is rebooting Monopoly after nearly a decade - this time with a digital twist - as the fast-food giant looks to boost sales and drive customers to its app. R-J Hottovy, Head of Analytical Research at the Palo Alto-based foot traffic analysis firm Placer.ai, joins Andy Dahn on the WBBM Noon Business Hour with the details.

What's it like to live in Burlingame, California?In this series, we explore the most desirable communities across the Bay Area — giving you an insider's look at where locals live, work, and play. Whether you're relocating, investing, or just exploring your options, this is the BEST vlog series for understanding the lifestyle, real estate, and amenities in top Bay Area neighborhoods.This week, we're heading to Burlingame — “The City of Trees”. Just 17 miles south of San Francisco and under 30 minutes to Silicon Valley, Burlingame is one of the Peninsula's most convenient and charming towns. With walkable downtowns, highly rated schools, and a mix of historic homes and modern estates, it's one of the most desirable places to live in the Bay Area.

James sits down with cybersecurity pioneer HD Moore, the legendary founder of the Metasploit framework, whose journey from dumpster-diving teenager to cybersecurity pioneer was anything but easy.   HD recounts how Microsoft called his employer weekly trying to get him fired for releasing exploits — harassment that ultimately motivated him to "drop zero days continuously, forever, until it got normal." He shares tales of accidentally controlling satellite systems after following network hops too far, backdooring 7,000 systems through tainted warez, and spending $80,000 on his personal credit card to build the Rapid7 team when traditional corporate processes moved too slowly. From crawling through school windows at 5 AM to access Apple computers as a poor kid, to discovering that Palo Alto devices were leaking 5,000 customers' domain admin passwords to internet scanners, HD's stories illuminate the wild early days when vulnerability research was considered criminal activity rather than corporate necessity. Discover how he accidently destroyed his first self-built computer, why his ex-wife held a pile of cash as bail money ready during years of FBI visits, and how the Phrack IRC channel became an unlikely recruitment ground for his first cybersecurity job.

Drs Kaniksha Desai and Julie Ann Sosa discuss the 2025 American Thyroid Association guidelines for the management of differentiated thyroid cancer. This podcast is intended for healthcare professionals only. Kaniksha Desai, MD, Associate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo Alto, California Julie Ann Sosa, MD, Professor, Department of Medicine, University of California, San Francisco (UCSF) To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0

Highlights from this week's conversation include:Michaela's Career Journey and Entry into Impact Investing (1:06)Lessons from Early Impact Experiences (3:36)Misconceptions about Impact Investing and Returns (6:39)Lessons from Clean Energy Investments (10:11)Venture and Asset Class Inclusion in Impact (12:03)Capricorn's Ecosystem Building and Value Add (15:59)Current Client Questions and Market Backlash (17:49)Strategies and Dislocations in Capital Markets (19:39)Marie-Celine's Background and Role at Capricorn (22:40)Asset Class Commitments (25:10)GP Engagement and Inflection Points (26:49)Investment Excellence and Entrepreneurial Teams (29:01)LP Relationships and GP Support (31:17)Mission Alignment for GPs (34:02)Due Diligence, Regulatory Risk, and Diversification (35:49)Connecting with Capricorn and Parting Thoughts (37:19)Capricorn Investment Group is a $13B mission-aligned investment firm founded on the belief that sustainable investment practices can enhance risk-adjusted returns. With offices in New York City and Palo Alto, Capricorn invests across asset classes, from venture capital to GP staking, supporting scalable solutions to the world's most pressing problems. Learn more at www.capricornllc.com.Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of the world's most innovative companies and investors. SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVB's parent company, First Citizens BancShares, Inc. (NASDAQ: FCNCA), is a top 20 U.S. financial institution with more than $200 billion in assets. First Citizens Bank, Member FDIC. Learn more at svb.com.Swimming with Allocators is a podcast that dives into the intriguing world of Venture Capital from an LP (Limited Partner) perspective. Hosts Alexa Binns and Earnest Sweat are seasoned professionals who have donned various hats in the VC ecosystem. Each episode, we explore where the future opportunities lie in the VC landscape with insights from top LPs on their investment strategies and industry experts shedding light on emerging trends and technologies. The information provided on this podcast does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this podcast are for general informational purposes only. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this episode, Dr. Gabrielle Lyon sits down with Dr. Teo Soleymani, a fellowship-trained skin cancer surgeon and dermatologist, to cut through the noise of the skincare industry. They discuss everything from viral trends like "glass skin" to the science behind hormones, sun protection, and the lifestyle factors that truly determine your skin's health and longevity.Dr. Teo Soleymani debunks common myths and provides actionable, no-nonsense advice on what to use—and what to avoid—to build a powerful, evidence-based skincare regimen. This conversation is a must-watch for anyone who wants to stop guessing about their skin and start seeing real results.Join the Forever Strong Menopause Challenge today and get your 4-week, science-based plan to build strength, improve sleep, and feel in control again: https://drgabriellelyon.com/forever-strong-menopause-challenge/Chapters:0:00 - Intro: K-Beauty, Multi-Step Routines & The Makeup Debate6:15 - The Dangers of Makeup & Environmental Toxins11:50 - The Shocking Effects of Hormones on Skin & Hair16:59 - How Testosterone & Estrogen Impact Your Skin22:58 - The Best Way to Use Hormones for Skin Health29:20 - The Rise of Social Media Doctors & Medical Misinformation33:24 - The TRUTH About Sun Exposure, Skin Cancer & Aging46:00 - The Crucial Role of Diet & Protein in Skin Health48:13 - Oral Collagen, Vitamin C & Skin Hydration54:12 - Treating Crepey Skin with Lasers & Topicals1:02:47 - Dr. Solommani's Perfect Anti-Aging Regimen1:14:03 - The Beef Tallow Debate & How to Choose a Moisturizer1:16:53 - Red Light Therapy for Skin & Hair Growth1:21:26 - The Truth About Minoxidil, PRP & Exosomes1:28:40 - The Best Oral Supplements for Internal Sun Protection1:34:01 - Sun Powder: An Internal Sunscreen1:40:56 - Final Thoughts & The Future of SkincareWho is Dr Soleymani:A Los Angeles native, Dr. Soleymani completed his undergraduate studies in Evolutionary Biology at UCLA. He went on to graduate from the University of California, Irvine School of Medicine, during which time he was awarded numerous accolades for academic excellence and was inducted into the prestigious Alpha Omega Alpha honor society, considered widely to be the highest award bestowed in medical school. Dr.Soleymani completed his internship at Cedars-Sinai Medical Center, where he was awarded the UCLA David Geffen School of Medicine Excellence in Teaching with Humanism Award. He then went on to complete his residency at Stanford University in Palo Alto, California, one of the world's most premier dermatology training programs. While at Stanford, Dr. Soleymani worked with world-renowned experts in cutaneous oncology and complex skin diseases and was the recipient of various academic awards and distinctions. This episode is brought to you by:Puori - Use code DRLYON for 20% off - https://puori.com/DRLYONARMRA - Use code DRLYON to get 15% off your first order - https://tryarmra.com/DRLYONBON CHARGE - Use code DRLYON to get 15% off your entire order - https://boncharge.com/DRLYONManukora - Get $25 off your Starter Kit at https://manukora.com/DRLYONFind Dr Soleymani at: Instagram: https://www.instagram.com/teosoleymanimdWebsite: https://www.californiadermatology.com/provider/teo-soleymani-md-faad-facmsFind Dr. Gabrielle Lyon at: Instagram:@drgabriellelyon TikTok: @drgabriellelyonFacebook: facebook.com/doctorgabriellelyonYouTube: youtube.com/@DrGabrielleLyonX...

Everyone knows about Linsanity. But in this episode, we take you back to Lin's childhood in Palo Alto, California where he was an undersized point guard who seemingly had no chance to make the NBA.CREDITSRick Loayza: Head researcher, writer, and voiceJacob Loayza: Editor, producer, and publisher MUSIC"Broken" by AJ PRO"Horizons" by Roa SPORTS HISTORY NETWORKsportshistorynetwork.comsportshistorynetwork.com/podcasts/basketball-history-101/ FACEBOOKm.facebook.com/Basketball-History-101-103801581493027/ BUSINESS CONTACTbballhistory101@gmail.comMentioned in this episode:Sports History Network Theme SongThis theme song was produced by Ron "Tyke" Oliver of Music Meets Sportz https://sites.google.com/view/sportsfanztastic/sports-history-network?authuser=0

All of you are taking Harinām initiation today. You may also say, 'Why is it that we take an initiation into a free mantra? I can get this downtown Palo Alto at Lytton Plaza. They just have to go and find the youth Harinām kīrtan and hang around, right?' "They're not selling it down there. They're just giving it away free, and Lord Caitanya gave it away free. 'Why do I have to take all these vows?' Well, Viśvanāth Cakravartī Ṭhākur answers this question in his commentary to the sixth canto of the Śrīmad Bhāgavatam regarding the power of chanting the holy name. He says, 'If you can get the holy name from a Vaiṣṇav who's gotten it from a Vaiṣṇav, and that's the definition of a Vaiṣṇav—someone who has received the mantra from a Vaiṣṇav and is following the Vaiṣṇavs. That's why we call it Vaiṣṇavism.' He said, 'And you don't take it, then you're committing the third offense against the chant of the holy name.' In other words, you've got an attitude problem because you think you can go it alone. We can't go it alone. We consider that any advancement we make, any step we take, is enabled by the mercy of Lord Caitanya Mahāprabhu, who's Kṛṣṇa Himself, allowing us the highest, the biggest dispensation ever given in the history of the world, in the history of the universe, in the history of all the universes. 'Anarpita-carīṁ cirāt karuṇayāvatīrṇaḥ kalau' means there's the biggest sale of all time going on. Lord Chaitanya is giving this process through his Vaiṣṇava devotees. So we take the humble route, and we take the mantra, the Hare Kṛṣṇa mantra, from a devotee who's following a devotee who's following a devotee all the way back to Kṛṣṇa. And then Bhaktivinod Ṭhākur says in his Harinām Cintāmaṇi, 'Success of the highest kind is available to such a person.' If one chants Hare Kṛṣṇa, incidentally, one can be freed from many sins. 'jaya nāmadheya muni-vṛnda-geya he' 'jana-rañjanāya param akṣarākṛte' 'tvam anādarād api manāg udīritaḿ' 'nikhilogra-tāpa-paṭalīṁ vilumpasi' (Nāmāṣṭakam Verse 2) Somebody says it derisively, it can be cleared from many sins. But if someone becomes sincere and says that this is my sole purpose in life—to remember Kṛṣṇa and the process recommended by Śukadev Gosvāmī, by the Śrīmad Bhāgavatam—a whole canto is dedicated to it: how to be extricated from the material world, but much more than that, how to develop love for Kṛṣṇa. It's just by chanting the Lord's Names, what to speak of Caitanya Mahāprabhu coming and demonstrating how this is the process in Kali Yuga. Anyone can take. All of you who are doing this today will change the world by your stance of unwavering dedication to the chanting of 16 rounds every day, minimum, following the four regulative principles. ------------------------------------------------------------ To connect with His Grace Vaiśeṣika Dāsa, please visit https://www.fanthespark.com/next-steps/ask-vaisesika-dasa/ ------------------------------------------------------------ Add to your wisdom literature collection: https://iskconsv.com/book-store/ https://www.bbtacademic.com/books/ https://thefourquestionsbook.com/ ------------------------------------------------------------ Join us live on Facebook: https://www.facebook.com/FanTheSpark/ Podcasts: https://podcasts.apple.com/us/podcast/sound-bhakti/id1132423868 For the latest videos, subscribe https://www.youtube.com/@FanTheSpark For the latest in SoundCloud: https://soundcloud.com/fan-the-spark ------------------------------------------------------------ #spiritualawakening #soul #spiritualexperience #spiritualpurposeoflife #spiritualgrowthlessons #secretsofspirituality #vaisesikaprabhu #vaisesikadasa #vaisesikaprabhulectures #spirituality #bhaktiyoga #krishna

In this episode, we welcome editor Glen Scantlebury, ACE. Glen has worked on a variety of influential films such as Megalopolis, Dracula, The Cotton Club, The Godfather Part III, Armageddon, Con Air, The Rock, Lara Croft: Tomb Raider, The Texas Chainsaw Massacre (2003), Friday the 13th (2009), A Nightmare on Elm Street (2010), Tropic Thunder, and Palo Alto. In our chat, we hear about his pathway to editing features, his role in pioneering digital editing workflows, collaborating with Francis Ford Coppola, and much more. Glen also offers the next generation of creators various insights and recommendations on editing and storytelling. “The Making Of” is presented by AJA:Gear up: AJA just launched new techFlexibility is everything in production, which is one of many reasons to check out AJA's newest products. IP25-R bridges SMPTE ST 2110 networks and 4K SDI/HDMI infrastructure, UDC-4K scales between HD and 4K/UltraHD, and BRIDGE LIVE 12G-4 provides a multi-channel UltraHD IP video workflow bridge for remote production, streaming, video contribution, and more. Learn more.Next-Gen DIY Storage, UnleashedThe OWC Express 1M2 80G delivers over 6000 MB/s real-world performance using the latest USB4 v2 (80 Gb/s) interface, with Thunderbolt 5 compatibility for next-gen workflows. Choose a ready-to-run or DIY enclosure—upgradeable to 8 TB using NVMe M.2 SSDs. Its passive heatsink design ensures silent, consistent speeds, all in a bus-powered, palm-sized form factor. Explore hereThe Art of Editing “Andor” with Yan Miles, ACE: OWC Takes Home Two Future's Best of IBC2025 Show Awards:Both the OWC Thunderbolt 5 Dual 10GbE Network Dock and OWC Jellyfish S24 Earn Coveted Honor at IBCOther World Computing announced its OWC Thunderbolt 5 Dual 10GbE Network Dock and its OWC Jellyfish S24 have both been awarded a Future's Best of Show Award, presented at IBC2025 by TVBEurope. Read more here Introducing Ninja TX:Introducing Ninja TX, the all-new addition to the Ninja family. It's equipped with 12G-SDI and HDMI, so now you can monitor & record from any pro camera to ultra-fast CFexpress media or external USB-C storage. You also get built in Wi-Fi for C2C workflows and AirGluTM timecode for multicam projects, all in a lightweight, compact 5-inch form factor. Atomos Ninja TX is available for pre-order for only $999 at Videoguys.com. Learn more herePost|Production World NY 2025:We're proud to support Post|Production World NY 2025, October 22–23 at NAB Show New York. Join editors, filmmakers, and creators for two days of expert-led sessions in color grading, cinematography, workflows, and creative AI. Save 15% with code FMCP15. Get your pass herePodcast Rewind:Sept 2025 - Ep. 95…Sponsor “The Making Of” newsletter and reach 250,000 filmmakers, TV production pros, and content creators each week. For more info, email mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

EVEN MORE about this episode!Grief is not something to “get over”—it's a lifelong journey of learning how to live while honoring the memory of those we love. In this powerful episode, grief experts Dr. Gloria Horsley and Dr. Heidi Horsley share compassionate wisdom on navigating loss, breaking free from unrealistic timelines, and embracing the personal process of creating a “new normal.”Together, we explore the emotional, biological, social, and spiritual dimensions of grief, and highlight the unique challenges faced by families who've lost loved ones in service roles such as the military and firefighting. Gloria and Heidi discuss the importance of peer-to-peer support through organizations like TAPS, share personal stories of resilience, and reflect on gender differences in grieving and remarriage.You'll learn how unresolved grief can resurface years later, how joy and laughter can coexist with sorrow, and how forgiveness and post-traumatic growth can bring deep healing and purpose. Above all, this conversation reminds us that grief is not linear—it is unique, unpredictable, and filled with moments of both pain and profound spiritual growth.Join us for this heartfelt discussion on love, connection, and the strength of community in the face of loss.Guest Biography:Heidi Horsley, PhD is a licensed psychologist, social worker, and bereaved sibling. She is the Executive Director and co-founder of the Open to Hope Foundation, and co-hosts the award-winning Open to Hope cable television show and podcast. An Adjunct Professor at Columbia University and an award-winning author of eight books, Dr. Heidi maintains a private practice in NYC and has been featured on numerous media outlets, including 20/20. She serves on the advisory boards of TAPS (Tragedy Assistance Program for Survivors), the Elisabeth Kübler-Ross Foundation, and Peace of Mind Afghanistan (POMA). For a decade, she worked with the FDNY-Columbia University Family Guidance Program, supporting families of firefighters lost in the 9/11 attacks. Her doctoral research focused on the sudden death of a sibling.Gloria Horsley, PhD is a licensed marriage and family therapist, clinical nurse specialist, and president/cofounder of the Open to Hope Foundation. She co-hosts the award-winning Open to Hope TV and podcast, and previously served on the faculty of the University of Rochester School of Nursing and the Academy of Intuition Medicine. Gloria has co-authored 10 books, contributed to numerous publications, and appeared on major media outlets including The Today Show. She is a member of the Forbes Nonprofit Council and serves on the advisory boards for the Tragedy Assistance Program for Survivors (TAPS) and the Elisabeth Kübler-Ross Foundation. Widowed after 60 years of marriage, she is the mother of four children (including a deceased son) and grandmother to 10. Gloria and her partner, Dr. Frank Powers, divide their time between Palo Alto, CA, and Scottsdale, AZ.Episode Chapters:(0:00:01) - Understanding Grief and Healing(0:14:20) - Navigating Loss and Moving Forward(0:24:19) - Grieving Without Set Stages(0:38:31) - Navigating Grief and Finding Joy(0:46:01) - Lessons in Grief and Spiritual Growth➡️Subscribe to Ask Julie Ryan YouTube➡️Subscribe to Ask Julie Ryan Español YouTube➡️Subscribe to Ask Julie Ryan Português YouTube➡️Subscribe to Ask Julie Ryan Deutsch YouTube➡️Subscribe to Ask Julie Ryan Français YouTube✏️Ask Julie a Question!

Every CMO wants alignment with their CEO. But all too frequently, things go sideways. It turns into chasing growth at any cost, drowning in acronyms, or scrambling to justify marketing's seat at the revenue table. What if the real secret isn't louder advocacy, but clearer translation, seeing the world the way your CEO does?  That's the perspective Rohini Kasturi brings as CEO of HG Insights. Fresh off two bold acquisitions in just a few months, HG Insights is redefining revenue growth intelligence and giving CMOs a new way to frame growth, retention, and efficiency. Rohini's advice: Stop playing defense on budget lines and start leading with business outcomes. In this episode:  How CMOs can connect their work to the three CEO obsessions: Growth, retention, and efficiency  Why spotting churn signals early matters as much as chasing pipeline  What it takes to balance efficiency with agility… without cutting corners Plus:  The role of revenue growth intelligence in shaping GTM strategy  How acquiring TrustRadius and MadKudu expands HG Insights' platform  Why every marketing move should tie back to revenue, even on a longer timeline  What CMOs gain by learning to speak the language of the boardroom If you want to know how CEOs really think and how CMOs can match them step for step, this one's for you! BONUS: HG Insights it THE Official GTM Partner of CMO Huddles and one of the Founding Sponsors of the 2025's CMO Super Huddle in Palo Alto. Rohini will join for a panel on The Future of GTM. With sharp strategic insight and deep empathy for the CMO's ever-evolving role, Rohini offers a rare CEO perspective on what it takes to drive smarter, more connected growth in 2025 and beyond.  For full show notes and transcripts, visit https://renegademarketing.com/podcasts/ To learn more about CMO Huddles, visit https://cmohuddles.com/

In the early to mid-2000s Palo Alto was rocked by a cluster of teen suicides. For Suicide Prevention Awareness Month, we're airing a documentary from audio reporter and producer I-Yun Chan, who traveled to Palo Alto to help her understand her own loss, and what it means to live on after someone losing someone to suicide. This story was edited by Shereen Marisol Meraji and was made in the audio program at UC Berkeley's Graduate School of Journalism. It was engineered by Chris Hoff. This episode discusses suicide. If you are experiencing thoughts of suicide, call or text 988 to reach the National Suicide Prevention Lifeline. Learn more about your ad choices. Visit megaphone.fm/adchoices

My guest today is Jonathan Siddharth, co-founder and CEO of Turing.Jonathan incubated Turing in Foundation Capital's Palo Alto office in 2018. Since then, it has grown into a multi-billion dollar company that powers nearly every frontier AI lab: OpenAI, Anthropic, Google, Meta, Microsoft, and others. If you've seen a breakthrough in how AI reasons or codes, odds are Turing had a hand in it.Jonathan has a provocative thesis: within three years, every white-collar job, including the CEO's, will be automated. In this episode, we talk about what it will take to reach artificial superintelligence, why this goal matters, and how the agentic era will fundamentally reshape work. We also dig into his founder journey: what he learned from his first startup Rover, how he built Turing from day one, and how his leadership style has evolved to emphasize speed, intensity, and staying in the details.Jonathan has been at the edge of AI for years, and he has the rare ability to translate what's happening at the frontier into lessons for builders today.Hope you enjoy the conversation! Chapters: 00:00 Cold open00:02:06 Jonathan's backstory: his experience at Stanford00:06:37 Lessons from Rover00:08:39 Early Turing: incubation at Foundation Capital and finding PMF00:13:52 Why Turing took off00:15:12 Evolving from developer cloud to AGI partner for frontier labs00:16:49 How coding improved reasoning - and why Turing became essential00:20:38 Founder lessons: building org speed and intensity00:23:33 Why work-life balance is a false dichotomy00:24:17 Daily standups, flat orgs, and Formula One culture00:25:15 Confrontational energy and Frank Slootman's influence00:29:50 Positioning Turing as “Switzerland” in the AI arms race00:34:32 The four pillars of superintelligence: multimodality, reasoning, tool use, coding00:37:39 From copilots to agents: the 100x improvement00:40:00 Why enterprise hasn't had its “ChatGPT moment” yet00:43:09 Jonathan's thoughts on RL gyms, algorithmic techniques, and evals00:46:32 The blurring line between model providers and AI apps00:47:35 Why defensibility depends on proprietary data and evals00:55:20 RL gyms: how enterprises train agents in simulated environments00:57:39 Underhyped: $30T of white-collar work will be automated

Ordinary Judean families cry out under crushing debt, famine, and heavy Persian taxes, while their own nobles and officials exploit them for profit. Nehemiah responds with righteous anger, confronting the elites in a public assembly and demanding immediate restitution. He calls them back to God's Law, reminds them of their covenant duty, and sets the example himself when, as Governor over Judea, he refuses the governor's food allowance and instead provides for many out of his own wealth.  The Rev. Stewart Crown, pastor of Trinity Lutheran Church in Palo Alto, CA, joins the Rev. Dr. Phil Booe to study Nehemiah 5.   To learn more about Trinity Lutheran, visit trinitylutheranpaloalto.com. From rubble to renewal, Nehemiah shows how the Lord rebuilds not just walls but hearts. Brick by brick and prayer by prayer, we follow God's people through repentance, courageous leadership, fierce opposition, covenant renewal, and joyful dedication. This verse-by-verse series keeps Law and Gospel front and center, tracing the story from burned gates to the greater Builder — Christ Jesus — who secures a city that cannot fall. Expect honest history, practical application, and the steady comfort of God's promises when the work is heavy and critics are loud. Thy Strong Word, hosted by Rev. Dr. Phil Booe, pastor of St. John Lutheran Church of Luverne, MN, reveals the light of our salvation in Christ through study of God's Word, breaking our darkness with His redeeming light. Each weekday, two pastors fix our eyes on Jesus by considering Holy Scripture, verse by verse, in order to be strengthened in the Word and be equipped to faithfully serve in our daily vocations. Submit comments or questions to: thystrongword@kfuo.org.

Lords: * John * Avery * Jay Topics: * Being known for one thing and trying to do a different thing * https://jtholen.bandcamp.com/album/new-active-object * Finding instruments on the street * Accidentally arguing with sauna guy Microtopics: * Many-Time Topic Lord John Mystery. * Talking the plunge into the Topic Lords discord. * An unspoken constant presence like Seymour Glass in the Glass Family novels. * The Once and Future Musician. * Putting a formant filter on your organ so you can play the organ on Zoom. * Why pouring hot water sounds different from pouring cold water. * The sound of boiling hot urine. * The top rated coffee shop in San Francisco on Yelp for seven months in a row. * Remaining your coffee shop after Mark Zuckerberg in hopes that he'll show up in person. * Trying to open up a coffee shop in late 90s San Francisco and only realizing too late that it's 2016. * ADA compliant seating. * Four-person episodes of Topic Lords. * A 6'5" guy trying to barter a half-used spray paint can for a cup of coffee. * The Menacing Barterer. * Aggressive Wimpy gladly paying you tomorrow for a hamburger today or else. * Aggressive Wimpy throwing a shoe at your espresso machine. * Your car accidentally becoming an art car. * Letting people spray paint your car until it's nothing but spray paint. * Calling 911 and explaining that the guy menacing you needs marijuana. * Being detained by Mark Zuckerberg's private security force. * Living near Mark Zuckerberg's house so you can do whatever your fixation with Mark Zuckerberg is. * Aggressive Barter Guy trying to barter a Porsche for a cup of coffee. * The $6 Porsche. * Tholen or Tholen. * A prog album constructed from Klik n Play samples. * When someone who does I've things decides to do something else. * The Mountain Goats novelizations. * Leonard Cohen's terrible poetry. * Thinking a song is deeply meaningful until you read the lyrics. * New Active Object. * Lunch Music. * Doing a thing for a long time and getting good at it. * Who has time to read a novel? * Having Game Boys Advance but still reading books sometimes. * Telling your teacher that you need to go to your job at NASA and they're like "oh you must be doing something important over there" * Working in the waterslide industry. * The Joy of Being the Secrets Guy. * Reading too much into it is the next Frog Fractions game. * Admitting to your wife that you found a digital piano on the curb. * The digital piano in the background of the Frog Fractions 2 pitch video. * Walking by a theremin at a party and it chirps at you like a proximity car alarm. * The Moog Etherwave. * Staring at your broken Omnichord. * A toddler whose first word is "mandolin." * Living Out Yonder. * The Roland Space Echo. * A cassette tape except there isn't any cassette, the tape is just kind of wriggling around in there. * Buying synthesizers from thrift shops that don't know how to tell whether synthesizers are broken. * The Two Organs Behind Me. * Ukelins. * Zither-esques. * Dulcimers vs. hammered dulcimers. * Looping your song and picking the notes that kind of sound like they belong. * A Xylophone For Jandek. * Feeling like you're taking to extremely accomplished people and you're just a weird little guy. * Who Is Sauna Guy?? * Stuck debating sauna guy while the venerated author with similar interests to yours is holding court in the next room. * Physics Philosophy guy talking about physics and philosophy. * An hour into the conversation, telling Sauna Guy that you don't even like being warm and he just stares at you. * The new way to joke about forum URLs. * Back when the Internet was full of exciting possibilities. * What topics turn you into Sauna Guy. * David Byrne sitting alone at the David Byrne art exhibit in Palo Alto. * We're All Sauna Guy Now. * Voting each other off the podcast. * Lightning round sudden death topics. * When the sunscreen finally makes it onto your cornea. * Not having a home page again but meaning to someday.

In this week's episode, Steve and Brad set the stage for a pivotal stretch in the Sounders' season. They preview Saturday's home clash against LA Galaxy and look ahead to next Tuesday's showdown at Inter Miami, breaking down the key matchups and what's at stake in this final stretch of the regular season. With the Western Conference standings tightening, the hosts dive into where the Sounders could – and should – finish as the postseason approaches.The episode also features an in-depth interview with goalkeeper Andrew Thomas. He reflects on his standout performances during the Leagues Cup, shares the story of how he first fell in love with soccer growing up in England, and recounts his college journey at Stanford. Thomas also discusses the mentorship he's received from club legend Stefan Frei, and lets listeners in on some of his favorite local spots in Palo Alto.A blend of tactical insights, personal storytelling, and playoff context – this episode is a must-listen for Sounders fans gearing up for a crucial run of matches.

September 1998 – Palo Alto, CA. Tetris co-creator Vladimir Pokhilko was found dead with a stab wound on the right side of his neck. His wife, Elena Fedotova, and 12-year-old son, Peter Pokhilko, were brutally killed. The case was ruled a murder-suicide, but the local Russian community insisted it was a Mafia hit. More than twenty years later, investigators are still searching for the truth of what happened. For bonus episodes and outtakes visit: patreon.com/generationwhySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

00:00:00 – Power Outages & Alex Jones Madness The show kicks off with banter about coffee, power outages, and how this is "the one" episode to watch. Alex Jones clips are then featured—ranging from chaotic rants, bizarre Thomas Jefferson misquotes, and wild conspiratorial tangents about Santa costumes and secret grand juries. 00:10:00 – Red-Eyed Aliens & Sleep-Deprived Man The hosts tease a future segment about red-eyed alien abductions involving a Muslim-Christian couple in Australia. They also speculate on the Flatwoods Monster's glowing red eyes and mention the finale of The Secret of Skinwalker Ranch. Then, a story is discussed about a UK man who claims to have been unable to sleep for two years, detailing his horrifying physical and mental deterioration. 00:20:00 – Comets, Conspiracies & Star Trek Parallels The conversation continues about the sleepless man before shifting to a baffling space object called 3I-ATLAS. It's discussed as possibly being a probe or alien craft, with a supposed leaked NASA memo suggesting it's under intelligent control. The team humorously compares it to Star Trek plots involving alien communication. 00:30:00 – Bigfoot Corpse at the State Fair A man named “Snake” claims to have found and displayed a Bigfoot corpse at the New York State Fair. The hosts express skepticism, noting the suspicious nature of the body and lack of video evidence. Local news coverage is played, showing the man's enthusiastic claims about battling Bigfoots and showcasing the corpse to fairgoers. 00:40:00 – Critique of the Bigfoot Body & State Fair Highlights Further discussion of the suspect Bigfoot corpse ensues. It's described as looking like a glued-together arts and crafts project. The hosts then shift to reviewing the New York State Fair offerings—deep-fried food, rooster crowing contests, and odd musical acts. A humorous critique of tribute bands and bizarre fair events follows. 00:50:00 – Skull with a Stalagmite & Mayo Firestarter The show shifts to a 300,000-year-old skull found in Greece with a stalagmite growing through it, puzzling scientists. Then, a man in Spain is arrested for setting a café on fire after being denied mayonnaise. The team jokes about male rage, potential mayo clinics, and cultural condiment preferences. 01:00:00 – Stablecoins, Chinese Students & AI Mayhem Discussion jumps to financial headlines, including stablecoins potentially draining bank deposits and Donald Trump proposing to allow 600,000 Chinese students into U.S. colleges. The team jokes about “China” using an old Trump clip. News is also covered about a Saudi-built Islamic AI chatbot and a hacker who used AI to conduct a massive cyberattack. 01:10:00 – AI-Powered Cybercrime & Tacos The cyberattack details are expanded, noting how a hacker used AI to write ransomware demands and find exploitable data. Then, attention turns to a taco-eating contest in San Antonio offering a $10,000 prize. The sign-up has already closed, disappointing the hosts. Joe is humorously nominated to compete. 01:20:00 – Taco Contest Fallout & Zuckerberg's Bunkers Further complaints about the closed taco contest continue. The show then dives into Mark Zuckerberg's massive compound in Palo Alto, where he handed out noise-canceling headphones to neighbors due to constant construction. The hosts mock the billionaire's efforts to maintain privacy while disrupting the neighborhood with “hydro floors” and private schools. 01:30:00 – Zuckerberg's Noise Diplomacy The crew wraps up their critiques of Zuckerberg's sprawling estate, suggesting his gestures like wine and doughnuts to neighbors are tone-deaf. There's some light commentary on his bizarre bunker expansions and the absurdity of Silicon Valley billionaires. 01:40:00 – Orgy Dome Controversy at Burning Man The team discusses a controversy involving someone being kicked out of the “Orgy Dome” at Burning Man for witnessing something disturbing. They mock the corporatization of Burning Man, suggesting brands like Little Caesars or Taco Cabana might soon sponsor the orgy tent. An Instagram photo of the dome's condition is referenced, and there's satire about how far the festival has strayed from its roots. 01:50:00 – Pumpkin Spice Chaos & White Elephant Nightmares A bizarre story unfolds about someone ordering 25 pounds of pumpkin spice online, leading to jokes about spice jungles and white elephant gifts. The team riffs on absurd workplace gift exchanges, packages with suspicious wrapping, and household pumpkin spice overloads—flavored water, scented air, and even garden tools. The hosts end on this autumnal madness with a final round of laughs. Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research ▀▄▀▄▀ CONTACT LINKS ▀▄▀▄▀ ► Phone: 614-388-9109 ► Skype: ourbigdumbmouth ► Website: http://obdmpod.com ► Twitch: https://www.twitch.tv/obdmpod ► Full Videos at Odysee: https://odysee.com/@obdm:0 ► Twitter: https://twitter.com/obdmpod ► Instagram: obdmpod ► Email: ourbigdumbmouth at gmail ► RSS: http://ourbigdumbmouth.libsyn.com/rss ► iTunes: https://itunes.apple.com/us/podcast/our-big-dumb-mouth/id261189509?mt=2